THERAPEUTIC AGENTS

The use of a compound of the formula (I): (I) wherein R is hydroxy or 2-methoxyethylamino or a pharmaceutically acceptable salt thereof, in stimulating the 'atypical' .beta.-adrenoceptors in the gastrointestinal tract and thereby inhibiting gastrointestinal motility. These compounds may be...

Full description

Saved in:
Bibliographic Details
Main Authors HOLLOWAY, BRIAN R, GROWCOTT, JAMES W
Format Patent
LanguageEnglish
French
Published 31.01.1992
Edition5
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The use of a compound of the formula (I): (I) wherein R is hydroxy or 2-methoxyethylamino or a pharmaceutically acceptable salt thereof, in stimulating the 'atypical' .beta.-adrenoceptors in the gastrointestinal tract and thereby inhibiting gastrointestinal motility. These compounds may be used for treating medical conditions wherein inhibition of gastrointestinal motility is thought to be of value, such as in the treatment of inflammatory bowel disease, irritable bowel syndrome (IBS), non specific diarrhoea and dumping syndrome.
Bibliography:Application Number: CA19912046576